Latest Resources
25 July 2022
The battle over regulation of new breeding techniques in South Africa
– A blog by ACB Director Mariam Mayet Snapshot In October 2021, the South African (SA) government determined that the regulatory and risk assessment framework that exists for genetically modified organisms (GMOs) will also apply to new breeding techniques (NBTs), which make up a host of new genetic engineering technologies. This decision appears to follow […]
28 April 2022
The financialisation of malaria in Africa: Burkina Faso, rogue capital & GM /gene drive mosq...
(Veuillez cliquer ici pour lire en français) The African Centre for Biodiversity (ACB) hereby publishes a new research paper, titled, “The Financialisation of malaria: Burkina Faso, Rogue capital & GM/gene drive mosquitoes.” This paper seeks to understand the financialisation of malaria as a vehicle for rogue capital in a context of a weakened state (through […]
8 March 2022
Coalition demands a ban of Bt Cowpea in Nigeria and neighbouring West African countries
A coalition of non-governmental organisations, farmer groups and research experts from various African countries call on the Nigerian government to revoke the permits granted by Nigeria’s National Biosafety Management Agency (NBMA) to the Institute for Agricultural Research (IAR), Zaria, for the commercial release of genetically modified (Bt) Cowpea (PBR-Cowpea). This call was made yesterday in […]
10 December 2021
End of 2021 wishes from the ACB
As this year comes to a close, we give thanks to all of you, our friends, family, comrades, and to the ancestors that continue to guide and protect us all and this planet. We send thoughts and prayers, to all those that have lost loved ones. Take this time to breathe. To ground. To decompose. […]
22 January 2021
Tanzania cancels GMO trials again: Urgent need to uphold ban, disrupt false solutions and neo-col...
In a totally unexpected move, the newly appointed Tanzania Agricultural Minister, Prof Adolf Mkenda, in mid-January 2021 announced the cancellation of research trials involving genetically modified organisms (GMOs) in the country and the decision to put in place extra biosafety scrutiny of imported genetically modified (GM) seed. The decision was taken by the Minister in […]
15 December 2020
End of 2020 wishes from the ACB
Those who contemplate the beauty of the earth find reserves of strength that will endure as long as life lasts. There is something infinitely healing in the repeated refrains of nature — the assurance that dawn comes after night, and spring after winter. – Rachel Carson Dear ACB Friends and Family, As this unimaginable year […]
2 September 2020
Push back against risky and unsafe RNAi GM cassava cultivation in Kenya
An unproven genetically modified (GM) RNAi cassava variety is yet another staple food crop, after maize and banana, on the biotech industry’s agenda for commercial cultivation in Kenya. The brazen lack of safety tests contained in the Kenya Agricultural and Livestock Research Organisation’s (KARLO’s) application for cultivation, and disregard for adherence to biosafety best practise […]
23 July 2020
ACB’s first newsletter: July 2020
Reflections midway through a tumultuous year Greetings from the ACB! We are happy to share with you our first newsletter. The onset of the Covid-19 pandemic and ensuing flux has led to deep reflection, as we grapple with how to meet unprecedented challenges. And through the stringent lockdown, our agile and mostly young and women-led […]
20 June 2020
Stephen Greenberg’s departure from the ACB at the end of June 2020
Sadly, at the end of June, the ACB’s senior researcher Stephen Greenberg is departing from the ACB. In a joint letter by executive director Mariam Mayet and Stephen, they reflect on their journey together. We are writing together, Mariam and Stephen. We have found ourselves walking the same path for a number of years now, […]
20 April 2020
COVID-19: Access to medicine & implications for Africa
ACB brings you a new discussion paper Passer à la version française Clique aqui para a versão portuguesa Dear Friends and Colleagues, Expeditious and affordable access to medicines and other healthcare items will be critical to reducing the toll of COVID-19 in Africa. But if nothing is done to compel corporations to make their patents […]